E-LIB Suche - Ergebnisse für: Matko Kalac

1

P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHL..:

Kalac, Matko ; Hertzberg, Mark ; Cheah, Chan...
HemaSphere. 7 (2023) S3 - p. e60782b9 , 2023

Link: https://doi.org/10.1097/..

2

Real-world experience of combined treatment with azacitidin..:

Kalac, Matko ; Jain, Salvia ; Tam, Constantine S....
Blood Advances. 7 (2023) 14 - p. 3760-3763 , 2023

Link: https://doi.org/10.1182/..

3

CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for ..:

D'Ovidio, Tyler ; Ciccolini, Kathryn ; Kalac, Matko..
Cureus. , 2023

Link: https://doi.org/10.7759/..

4

N-quinoline-benzenesulfonamide derivatives exert potent ant..:

Kalac, Matko ; Mangone, Michael ; Rinderspacher, Alison...
iScience. 23 (2020) 12 - p. 101884 , 2020

Link: https://doi.org/10.1016/..

5

Acute cardiomyopathy following a single dose of doxorubicin..:

Farina, Kyle ; Kalac, Matko ; Kim, Sara
Journal of Oncology Pharmacy Practice. 27 (2020) 4 - p. 1011-1015 , 2020

Link: https://doi.org/10.1177/..

6

Reversal of CYLD phosphorylation as a novel therapeutic app..:

Xu, Xin ; Kalac, Matko ; Markson, Michael...
Cell Death & Disease. 11 (2020) 2 - p. , 2020

Link: https://doi.org/10.1038/..

7

An Update on the Use of Immunotherapy in the Treatment of L..:

Marron, Thomas U. ; Kalac, Matko ; Brody, Joshua
Current Hematologic Malignancy Reports. 12 (2017) 4 - p. 282-289 , 2017

Link: https://doi.org/10.1007/..

8

Brentuximab vedotin and bendamustine produce high complete ..:

Kalac, Matko ; Lue, Jennifer K. ; Lichtenstein, Emily...
British Journal of Haematology. 180 (2016) 5 - p. 757-760 , 2016

Link: https://doi.org/10.1111/..

9

The combination of hypomethylating agents and histone deace..:

Marchi, Enrica ; Zullo, Kelly M. ; Amengual, Jennifer E....
British Journal of Haematology. 171 (2015) 2 - p. 215-226 , 2015

Link: https://doi.org/10.1111/..

10

A critical appraisal of conventional and investigational dr..:

Kalac, Matko ; Quintás‐Cardama, Alfonso ; Vrhovac, Radovan..
Cancer. 110 (2007) 5 - p. 955-964 , 2007

Link: https://doi.org/10.1002/..

11

P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHL..:

Matko Kalac ; Mark Hertzberg ; Chan Cheah...
http://journals.lww.com/10.1097/01.HS9.0000969400.60782.b9. , 2023

Link: https://doi.org/10.1097/..

12

N-quinoline-benzenesulfonamide derivatives exert potent ant..:

Matko Kalac ; Michael Mangone ; Alison Rinderspacher...
http://www.sciencedirect.com/science/article/pii/S2589004220310816. , 2020

Link: https://doi.org/10.1016/..

13

Real-world experience of combined treatment with azacitidin..:

Kalac, Matko ; Jain, Salvia ; Tam, Constantine S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368677/. , 2023

Link: http://www.ncbi.nlm.nih...

14

P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHL..:

Kalac, Matko ; Hertzberg, Mark ; Cheah, Chan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429444/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Reversal of CYLD phosphorylation as a novel therapeutic app..:

Xu, Xin ; Kalac, Matko ; Markson, Michael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002447/. , 2020

Link: http://www.ncbi.nlm.nih...